Posts filtered by tags: Merck[x]


 

The Gates Foundation puts $120 million towards rolling out Merck's COVID-19 pill in poorer countries

The Bill and Melinda Gates Foundation said it's committing $120 million to help roll out a COVID-19 drug in poor nations. Frederic Stevens/Getty The Gates Foundation is putting $120 million towards helping poorer nations get Merck's COVID-19 pill. Merck applied for FDA authorization for its COVID-19 antiviral drug but it hasn't been approved yet. The money will go towards developing and making generic versions of the pill if it's approved. The Bill and Melinda Gates Foundat...
Tags: Africa, Trends, Merck, Bill Gates, World Health Organization, Fda, Bill and Melinda Gates Foundation, Bill, Gates, Gates Foundation, Reuters, Melinda Gates Foundation, Tech Insider, COVID-19, COVID, Tech Contributors


United States: Medical Products Supply Chain Week In Review – October 14, 2021 - Alston & Bird

Last week, AstraZeneca and Merck filed emergency use authorization (EUA) requests for their COVID-19 drugs.
Tags: News, Merck, United States, Astrazeneca, Alston, EUA


Merck COVID-19 Pill Sparks Calls for Access for Lower Income Countries

By Francesco Guarascio and Michael Erman(Reuters) - The plan to roll out Merck & Co's promising antiviral pill to treat COVID-19 risks...
Tags: Merck, Reuters, Merck Co, Francesco Guarascio, Michael Erman


The FDA could authorize the first COVID-19 pill in December - here's who may be eligible

Pills seen with the Merck logo in the background. Jakub Porzycki/NurPhoto/Getty Images The FDA will meet to discuss Merck's COVID-19 pill in late November, which means the treatment could get authorized in December. The drug seems to prevent vulnerable people from requiring hospitalization or dying. Here's how the pill works, who might be eligible to receive it, and where to find it. The first-ever COVID-19 pill could be available before the end of the year.This week, Merck and Rid...
Tags: Facebook, US, Trends, Merck, Fda, Mike Ryan, Ryan, Food and Drug Administration FDA, Georgia State University, Daria Hazuda Merck, Aria Bendix, Jakub Porzycki NurPhoto Getty, Merck and Ridgeback Biotherapeutics, Richard Plemper


What's in store for Moderna and J&J booster shots

Hello, Welcome to Insider Healthcare. I'm healthcare editor Leah Rosenbaum, and this week in healthcare news:An FDA advisory group recommended that people in high-risk groups get a booster shot of the Moderna COVID-19 vaccine;UnitedHealth has a new strategy to partner with hospital systems;Our reporters analyze the latest trends in healthcare investing. First - if you're headed out to Boston for the HLTH conference starting October 17, keep an eye out for some of the Insider team! We'...
Tags: Boston, Trends, Merck, Marie Claire, Fda, Pfizer, Andrew, Johnson Johnson, UnitedHealth, Andrew Witty, Optum, Moderna, Andrew Dunn, Sindhu Sundar, HLTH, Mohana Ravindranath


Storm brews over 46x price markup of Merck’s Thor-inspired COVID pill (ars technica)

Enlarge / Merck & Co. headquarters in San Francisco, California. (credit: Getty | Sundry Photography) A storm is brewing over the pricing and licensing of Merck's antiviral pill molnupiravir, which the pharmaceutical giant says can halve the risk of hospitalization and death in high-risk COVID-19 patients. Merck's advance purchase agreement with the US government pegs the price of a five-day treatment at about $700. But an independent analysis by public health researchers at Harvard es...
Tags: News, India, US, Merck, Harvard, Getty, Thor, Beth Mole, San Francisco California, Merck Co


The Latest: FDA Likely to Rule on Virus Pill in December

The Food and Drug Administration will ask its outside experts to meet Nov. 30 to scrutinize Merck’s pill to treat COVID-19.
Tags: Merck, Food And Drug Administration, Fda


FDA Unlikely to Rule on Merck's COVID Pill Before December

The U.S. Food and Drug Administration will ask its outside experts to review Merck's pill to treat COVID-19 at a meeting in late November.
Tags: Merck, Fda, U S Food and Drug Administration


Merck's COVID-19 Drug to Be Reviewed by U.S. FDA Advisers Bloomberg News

(Reuters) -The U.S. Food and Drug Administration will send drugmaker Merck & Co's experimental COVID-19 antiviral drug to a panel of its...
Tags: Merck, Reuters, U S Food and Drug Administration, Merck Co, FDA Advisers Bloomberg News


UnitedHealth is setting its sights on hospitals

Hello,Welcome to Insider Healthcare. I'm healthcare editor Leah Rosenbaum, and today in healthcare news:UnitedHealth has a new plan to partner with hospital systems;A highly anticipated boosters trial found that J&J shot recipients got a better immune response with Pfizer and Moderna;Merck could make billions of its COVID-19 pill. If you're new to this newsletter, sign up here. Comments, tips? Email me at [email protected] or tweet @leah_rosenbaum. Let's get to it... Optum ...
Tags: US, Trends, Merck, Pfizer, Marlboro, UnitedHealth Group, UnitedHealth, J J, Moderna, COVID, Insider Healthcare, Molnupiravir, Leah Rosenbaum, Johnson Johnson Janssen, Eduardo Sanz Europa Press, Merck Merck


Merck wants Americans to pay $712 for a Covid drug that taxpayers helped develop | David Sirota

The drug in question only costs $17.74 to produce. Unfortunately, this type of behaviour is widespread in US pharmaLast week, we learned that Merck is planning to charge Americans 40 times its cost for a Covid drug whose development was subsidized by the American government. The situation spotlights two sets of facts that have gone largely unmentioned in the legislative debate over whether to let Medicare negotiate for lower drug prices.Fact one: Americans are facing not merely expensive drugs b...
Tags: US, Merck, World news, US news, Medicare, US healthcare, David Sirota


Holocene Advisors Says Merck's Offer Undervalues Acceleron

(Reuters) - Investment management firm Holocene Advisors said it will not tender its shares in Acceleron Pharma Inc into Merck & Co's proposed...
Tags: Merck, Merck Co, Reuters Investment, Acceleron Pharma Inc, Holocene Advisors


Merck is set to make billions off a COVID-19 pill that could change the pandemic. Here's why some countries will pay more than others.

Molnupiravir is an experimental oral antiviral developed by Merck and Ridgeback Biotherapeutics that could treat COVID-19. Merck Merck's COVID-19 pill holds tremendous promise in fighting the pandemic. Industry analysts expect Merck to make billions off the not-yet-authorized drug. Some countries will be paying $12 per pill, while the US agreed to pay $712 per treatment course. Merck is walking a tightrope with its COVID-19 pill, expecting to reap billions in revenue while still makin...
Tags: Health, Science, News, Africa, US, Trends, Merck, Joe Biden, Gotham, Harvard University, Healthcare, Middle East, Biotech, Bernstein, Gilead Sciences, Harvard Medical School


The FDA could authorize the first COVID-19 pill before year's end - here's who may be eligible to take it

Pills seen with the Merck logo in the background. Jakub Porzycki/NurPhoto/Getty Images Merck asked the FDA on Monday to authorize its COVID-19 pill for adults with mild to moderate COVID-19. The drug could help prevent vulnerable people from requiring hospitalization or dying. Here's how the pill works, who's eligible to receive it, and where to find it. The first-ever COVID-19 pill could be available very soon.On Monday, Merck and Ridgeback Biotherapeutics asked the Food and Drug ...
Tags: Facebook, US, Trends, Merck, Fda, Mike Ryan, Ryan, Food and Drug Administration FDA, Georgia State University, Daria Hazuda Merck, Aria Bendix, Ridgeback Biotherapeutics, Jakub Porzycki NurPhoto Getty Images Merck, Richard Plemper


EU May Consider Deal on Merck's COVID Pill After Approval Procedure Begins - Source

By Francesco Guarascio(Reuters) - The European Union may consider signing a supply deal with U.S. drugmaker Merck for its experimental COVID-19...
Tags: Merck, Eu, European Union, Reuters, Francesco Guarascio


The needle-free COVID-19 treatments undergoing testing right now

Hello,Welcome to Insider Healthcare. I'm healthcare editor Leah Rosenbaum, and today in healthcare news:Here are the needle-free COVID-19 treatments undergoing testing right now;What you need to know about kids getting the Pfizer vaccine;AstraZenca's new antibody drug is the first that's shown to prevent and treat COVID-19.If you're new to this newsletter, sign up here. Comments, tips? Email me at [email protected] or tweet @leah_rosenbaum. Let's get to it... While ...
Tags: Kids, Kaiser Permanente, Trends, Merck, Teenagers, New York Times, Healthcare, Pills, Astrazeneca, Fda, Pfizer, Vaccine, Antibodies, Pasadena Calif, Fauci, Newsletters


10 Things in Politics: Texas amps up vaccine fight

Welcome back to 10 Things in Politics. Sign up here to receive this newsletter. Plus, download Insider's app for news on the go - click here for iOS and here for Android. Send tips to [email protected]'s what we're talking about:Gov. Greg Abbott issued an executive order barring private companies in Texas from mandating COVID-19 vaccinesInsider is suing the Biden administration for secret Trump and Pence staffing recordsStephanie Grisham doesn't want forgiveness. She ju...
Tags: Facebook, South Korea, Hollywood, Texas, Washington, North Korea, White House, US, Dallas Mavericks, NFL, Raiders, Trends, Merck, Joe Biden, Ap, New York Times


Dr. Scott Gottlieb says Merck's Covid pill ‘can make a real difference’

Dr. Scott Gottlieb explains why he thinks the Merck Covid pill ‘can make a real difference.’
Tags: Merck, Scott Gottlieb, Merck COVID


Top Stories this PM: Merck requests authorization for anti-COVID pill; Facebook Oversight Board to meet with whistleblower

Good afternoon. Here are the top stories so far today.For more daily and weekly briefings, sign up for our newsletters here.What happened today:Merck requests authorization for anti-COVID pill. Merck submitted an application for emergency use authorization to the FDA for its COVID-19 antiviral pill, the company said Monday. If authorized, the drug, called molnupiravir, would become the first oral antiviral treatment for COVID-19. Molnupiravir, jointly developed by Merck and Ridgeback Biotherapeu...
Tags: Facebook, News, Supreme Court, Superman, Dc Comics, Newsletter, Trends, Merck, Bitcoin, General Services Administration, Fda, Biden, Donald Trump, Trump, Board, Mike Pence


The first-ever COVID-19 pill may be just weeks away. A handful of other pills, inhalers, and nasal sprays also show promise.

A man holds a capsule. Photographer, Basak Gurbuz Derman/Getty Images Treating COVID-19 could be simpler soon, thanks to the next generation of treatments. These could come in the form of pills, nasal sprays, or inhalers. On Monday, Merck asked the FDA to authorize its antiviral pill, which would be the first COVID-19 treatment of its kind. See more stories on Insider's business page. COVID-19 could get a lot easier to treat in the near future.Thus far, doctors have relied on expensiv...
Tags: UK, Science, News, Israel, US, Trends, Merck, Spain, Pills, Fda, Pfizer, Antiviral, Inhaler, Roche, Food and Drug Administration FDA, David Ramos Getty


AstraZeneca says its COVID-19 drug cuts the risk of severe disease in half. It's the first antibody cocktail shown to both prevent and treat the disease in late-stage trials.

Dan Pelletier, a pharmacy technician specialist at Maine Medical Center, demonstrates the process of preparing antibodies used to treat COVID19 patients. Derek Davis/Portland Press Herald/Getty Images AstraZeneca said its antibody drug cut the risk of severe COVID-19 in half in a late-stage study. The drug, called AZD7442, is a combination of two antibodies given as an injection. AstraZeneca said it's the only drug of its kind shown to both prevent and treat COVID-19. AstraZeneca's...
Tags: Health, UK, Science, News, US, Trends, Merck, Healthcare, Astrazeneca, Fda, Antibody, Ward, Food and Drug Administration FDA, Kings College London, Maine Medical Center, Mene Pangalos


Merck seeks FDA emergency use authorization for Covid-19 treatment pill

Merck said Monday it is seeking US Food and Drug Administration emergency use authorization for its experimental antiviral Covid-19 treatment, molnupiravir.
Tags: News, Merck, Stories, Fda, US Food and Drug Administration


Merck asks FDA for emergency approval of its antiviral COVID-19 pill

Pharmaceutical giant Merck and its partner Ridgeback Biotherapeutics announced Monday that it has asked the Food and Drug Administration...
Tags: Merck, Fda, Ridgeback Biotherapeutics


Merck asks FDA to authorize antiviral Covid pill for emergency use

The Covid-19 treatment – known as molnupiravir – could be available to Americans by late this year.
Tags: Merck, Fda


Merck Asks US Regulators to Authorize Promising Pill Against COVID-19, With Decision Expected Within Weeks

Merck asks US regulators to authorize promising pill against COVID-19, with decision expected within weeks.
Tags: US, Merck, COVID, Merck Asks US Regulators


Merck seeks FDA emergency use authorization for antiviral Covid-19 treatment molnupiravir

Merck said it is seeking FDA emergency use authorization for its experimental antiviral Covid-19 treatment, molnupiravir.
Tags: Merck, Cnn, Fda


Merck requests FDA authorization for its anti-COVID-19 pill, the next step towards rolling it out

Capsules of molnupiravir, the antiviral COVID-19 pill from Merck and Ridgeback Biotherapeutics. Merck Merck said Monday it had applied for FDA authorization for its COVID-19 antiviral drug. If cleared, it would be the first oral antiviral in use for COVID-19. Early trial results suggested the pill reduces hospitalization by 50%, the company said. Merck is seeking authorization for its COVID-19 antiviral pill, the company said Monday in a joint statement with Ridgeback Biotherapeutics. Th...
Tags: Trends, Merck, Bloomberg, Fda, Pfizer, Roche, US Food and Drug Administration FDA, Andrew Dunn, Ridgeback Biotherapeutics, Marianne Guenot, Molnupiravir, Ridgeback Biotherapeutics Merck Merck


Timing Is Everything for Merck’s COVID Pill

The drug, molnupiravir, is named after Thor’s hammer, Mjölnir. But its power depends on reaching the right people, in the right time frame.
Tags: Management, Merck, Thor


10 things before the opening bell

Goldman Sachs app SOPA Images/ Getty Images Welcome to 10 Things Before the Opening Bell.If this was forwarded to you, sign up here. Plus, download Insider's app for news on the go - click here for iOS and here for Android.Join our live event Oct. 14: What employers can do to support working parents. Register here.Let's get into it.1. Global stocks are rising after McConnell offered to extend the debt ceiling deadline to December. With a US default less likely, Friday's monthly ...
Tags: US, Trends, Merck, Nintendo, SEC, Goldman Sachs, Robinhood, Carl Icahn, Gensler, McConnell, Gary Gensler, Southwest Gas, Phil Rosen, Cathie Wood, COVID, Phil Rosen Feedback


Passive Income Update: September 2021

My Passive Income Pyramid It’s near the start of a new month, so that means I have the financial numbers to review for last month. Before we get into the numbers, here’s a little personal review. The best part of September was that I felt very happy the whole month. That’s not usually the case. I capped off almost every night in our inflatable hot tub spa with some streaming service on a tablet. Sometimes I’d just pause the show and look up at the stars and listen to the crickets for a mi...
Tags: Marketing, Merck, Julia Roberts, Delta, Zillow, Newport, Newport RI, Gregg, Ash Ketchum, Alternative Income, Passive Income, Miranda Marquit, Improtu